| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/24/2002 | US20020009750 Monoclonal antibodies specific to vegf receptors and uses thereof |
| 01/24/2002 | US20020009749 Diagnostic drugs for autoimmune diseases |
| 01/24/2002 | US20020009739 Metastatic breast and colon cancer regulated genes |
| 01/24/2002 | US20020009726 CD40 associated proteins |
| 01/24/2002 | US20020009708 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 01/24/2002 | US20020009465 Vaccines |
| 01/24/2002 | US20020009461 Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases |
| 01/24/2002 | US20020009455 Prostate glands; diagnosis, therapy |
| 01/24/2002 | US20020009453 Polyclonal antibody composition for treating allergy |
| 01/24/2002 | US20020009451 New monoclonal antibodies which identify the glycoprotein carrying the ca125 epitope |
| 01/24/2002 | US20020009450 Administering antagonist to surface receptors |
| 01/24/2002 | US20020009449 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction |
| 01/24/2002 | US20020009447 Vaccinia virus infections |
| 01/24/2002 | US20020009446 Method of modulating memory effector T-cells and compositions |
| 01/24/2002 | US20020009445 Pufification of human immunoglobulin using chromatography |
| 01/24/2002 | US20020009444 Brain disorders using monoclonal antibodies |
| 01/24/2002 | US20020009443 Binding to platelet-devived growth factor |
| 01/24/2002 | US20020009442 Diagnosis, therapy Aids |
| 01/24/2002 | US20020009441 Administering mixture of binding agent and active materials |
| 01/24/2002 | US20020009440 Method for separating cells using immunorosettes |
| 01/24/2002 | US20020009439 Central nervous system disorders therapy; genetic engineered culture; Alzheimer's disease |
| 01/24/2002 | US20020009430 Isolation of tumor cells; incubation |
| 01/24/2002 | US20020009429 Pharmaceutical composition comprising a selected antigen and candida species antigen and methods |
| 01/24/2002 | US20020009427 Methods of therapy for non-hodgkin's lymphoma |
| 01/24/2002 | US20020009417 Nucleosome-based anti-tumor compositions |
| 01/24/2002 | DE10033939A1 Composition containing egg yolk antibodies and optionally microalgae extracts and oxytetracycline, useful for treatment of inflammatory conditions, especially wounds |
| 01/24/2002 | DE10032608A1 Für mikrosatelliteninstabile (MSI+)-Tumore relevante Gene und ihre Genprodukte For microsatellite instability (MSI +) - related tumors genes and their gene |
| 01/24/2002 | DE10030466A1 Nukleotid- und Aminosäurensequenzen eines zellulären Repressors der DNA Replikation des Herpesvirus Epstein-Barr Nucleotide and amino acid sequences of a cellular repressor of DNA replication of the herpes virus Epstein-Barr |
| 01/24/2002 | CA2418391A1 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 01/24/2002 | CA2418207A1 Dendritic cell-derived nucleic acids and related compositions and methods |
| 01/24/2002 | CA2416452A1 Novel proteins and nucleic acids encoding same |
| 01/24/2002 | CA2416285A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 01/24/2002 | CA2416179A1 Novel dna polymerase iii holoenzyme delta subunit nucleic acid molecules and proteins |
| 01/24/2002 | CA2415751A1 Masp-2, a complement-fixing enzyme, and uses for it |
| 01/24/2002 | CA2415690A1 Tetraspan protein and uses thereof |
| 01/24/2002 | CA2415687A1 Novel g-protein coupled receptor |
| 01/24/2002 | CA2415557A1 Compounds for the treatment of sexual dysfunction |
| 01/23/2002 | EP1174523A2 Method for detecting an HBV-derived nucleic acid target sequence |
| 01/23/2002 | EP1174506A1 C-terminal Erns peptide and analogues thereof |
| 01/23/2002 | EP1174505A1 (Poly)peptides for the preparation of vaccines against Bordetella pertussis and/or Bordetella parapertussis, vaccines based upon such (poly)peptides, and antibodies against such peptides |
| 01/23/2002 | EP1174503A1 Novel proteins, gene encoding the same and method of utilization thereof |
| 01/23/2002 | EP1174502A1 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
| 01/23/2002 | EP1174441A2 Antibodies and fv fragment recognizing antigen ior c2 |
| 01/23/2002 | EP1174440A1 A selectively-expressed epitope on the human CD38 molecule detected by a phage display library-derived human scFv antibody fragment |
| 01/23/2002 | EP1174148A1 Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same |
| 01/23/2002 | EP1173766A1 A tenascin-c isoform as a marker for neoplasias |
| 01/23/2002 | EP1173765A1 Diagnostic and therapeutic use of antibodies against the urokinase receptor |
| 01/23/2002 | EP1173619A2 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
| 01/23/2002 | EP1173588A1 Nucleic acid molecule, containing a nucleic acid which codes for a polypeptide with chorismate mutase activity |
| 01/23/2002 | EP1173587A1 Dsp-10 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173586A1 Dsp-8 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173571A2 Human ion channel proteins |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173565A1 Adipocyte complement related protein homolog zacrp3 |
| 01/23/2002 | EP1173563A1 Compositions and methods for the treatment of tumour |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173556A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such |
| 01/23/2002 | EP1173552A2 Carbohydrate-modifying enzymes |
| 01/23/2002 | EP1173486A1 Antibodies that recognize app cleaved by caspases and methods of use |
| 01/23/2002 | EP1173485A1 Human antibodies to staphylococcus aureus |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173465A1 Novel human voltage-gated potassium channel |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173461A1 50 human secreted proteins |
| 01/23/2002 | EP1173456A1 Secreted proteins and nucleic acids encoding them |
| 01/23/2002 | EP1173202A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies |
| 01/23/2002 | EP1173201A1 Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit |
| 01/23/2002 | EP1173200A1 Composition for neuronal regeneration comprising myelin-specific antibodies and complement proteins |
| 01/23/2002 | EP1173195A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/23/2002 | EP0797590B1 Neurotrophic peptides of activity dependent neurotrophic factor |
| 01/23/2002 | EP0704056B9 Leukocyte adhesion assay |
| 01/23/2002 | EP0623144B1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332797A Bleaching enzymes and detergent compositions comprising them |
| 01/23/2002 | CN1332748A Isolated nucleic acid molecules which encodt T cell inducible factors (TIFs), proteins encoded, and uses thereof |
| 01/23/2002 | CN1332631A Composition and method for increasing weight gain and feed efficiency |
| 01/23/2002 | CN1332251A Production process of infections chicken cloacal bursa virus resisting monoclonal antibody |
| 01/23/2002 | CN1332240A Superoxide dismutase-4 |
| 01/23/2002 | CN1078250C Reshaped monoclonal antibodies against immunoglobulin isotype |
| 01/22/2002 | USRE37525 Concurrent administration of acetylsalicylic acid, corticosteroid, indomethacin, or ibuprofen antiinflammatory agent and human immunoglobulin g to treat bronchiolitis caused by respiratory syncytial or parainfluenza virus |
| 01/22/2002 | US6340743 Antibody ligands for specific binding to stalk of polymeric immunoglobulin receptor of cell with proviso that ligand does not bind to secretory component of receptor |
| 01/22/2002 | US6340740 An isolated polypeptide involved in modulating apoptotis; therapy for acquired immunodeficiency syndrome (aids), nervous system disorders and ischemic injury |
| 01/22/2002 | US6340701 Taxanes chemically linked to cell binding agent for delivering to specific cell population in targeted fashion |
| 01/22/2002 | US6340577 Protein fragments for use in protein targeting |
| 01/22/2002 | US6340575 An isolated nucleic acid encoding a ras superfamily, rac gene, that modulates gtpase activity; cancer therapy |
| 01/22/2002 | US6340571 Antibodies specific for Staphylococcus aureus, and use thereof |
| 01/22/2002 | US6340569 Monoclonal antibody and antigens specific therefor and methods of using same |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | CA2259962C Therapeutic applications of t-bam (cd40l) technology to treat diseases involving smooth muscle cells |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/22/2002 | CA1341333C Amylin peptides and uses thereof |
| 01/18/2002 | CA2349743A1 Diagnostic assay |
| 01/17/2002 | WO2002004643A1 Tumor necrosis factor-gamma |
| 01/17/2002 | WO2002004642A1 Novel polypeptide and dna thereof |
| 01/17/2002 | WO2002004636A1 NOVEL α-CATENIN EXPRESSED IN HEART AND TESTIS |
| 01/17/2002 | WO2002004612A2 Drug metabolizing enzymes |
| 01/17/2002 | WO2002004611A2 Aminoacyl trna synthetases |
| 01/17/2002 | WO2002004607A1 Human myeloma cell line |